常州市存仁生物工程有限公司

产品 > Receptor Tyrosine Kinases > IGF-IR > Linsitinib(OSI906)
产品名称 : Linsitinib(OSI906)
型号 : CR1207
CAS : 867160-71-2
 放大                   返回
←[上一个产品]              [下一个产品]→


产品详细:
Description of:Linsitinib(OSI906)
Linsitinib(OSI906) is a potential first-in-class selective small molecule, dual kinase inhibitor of both insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor (IR). OSI-906 is currently in a Phase III clinical trial in adrenocortical carcinoma (ACC) and in a Phase I/II clinical trial in ovarian cancer. 

Theoretical analysis:Linsitinib(OSI906)
M.Wt:421.49
Formula: C26H23N5O
Solubility: Unknown
Purity: >98%
Storage: at -20℃ 2 years
CAS No: 867160-71-2

Availability and price:Linsitinib(OSI906)
Pakage:25mg/50mg/100mg/250mg/500mg/1g/5g
Stock : in stock
We offer significant discount for larger quantity order.
For quotation, question, and order, please send email to :
orders@chemrenblock.com

Quality control data:
Quality Control by H-NMR,C-NMR,LC-MS,HPLC.
Product will be shipped with supporting analytical data.
Fast delivery about 4-5 working days


相关产品 :
NVP-ADW742
NVP-ADW742
GSK1904529A
GSK1904529A
BMS-754807
BMS-754807
AVP-AEW541
AVP-AEW541
NVP-ADW742
NVP-ADW742
BMS-536924
BMS-536924
NVP-AEW541
NVP-AEW541